The Świętokrzyskie Oncology Center is responsible in the CAR-NET project for preparing a lentiviral vector that will carry genetic information inside the patient's T lymphocytes. Based on this information, the lymphocytes will build a receptor on their surface so that they can recognize and destroy cancer cells.
Biotechnologists have harnessed the natural potential of lentiviruses (in this case HIV) to infect lymphocytes. The method is safe for the patient, because for the preparation of the lentiviral vector the active virus will not be used, but only its envelope (it is produced at the Plant in an incubator in the vector production stage), in which information in the form of DNA will be placed. The task of the vector is only to transfer the information inside the T lymphocytes, it is not capable of living and multiplying on its own in the patient's body. It is such a 'molecular porter'
